KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Debt Ratio (2019 - 2025)

Vir Biotechnology's Debt Ratio history spans 5 years, with the latest figure at 0.01 for Q1 2025.

  • For Q1 2025, Debt Ratio changed N/A year-over-year to 0.01; the TTM value through Mar 2025 reached 0.01, changed N/A, while the annual FY2024 figure was 0.01, N/A changed from the prior year.
  • Debt Ratio for Q1 2025 was 0.01 at Vir Biotechnology, up from 0.01 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.06 in Q3 2021 and bottomed at 0.01 in Q4 2024.
  • The 3-year median for Debt Ratio is 0.02 (2021), against an average of 0.03.
  • The largest YoY upside for Debt Ratio was 254.33% in 2021 against a maximum downside of 4.19% in 2021.
  • A 3-year view of Debt Ratio shows it stood at 0.06 in 2021, then plummeted by 79.72% to 0.01 in 2024, then grew by 16.56% to 0.01 in 2025.
  • Per Business Quant, the three most recent readings for VIR's Debt Ratio are 0.01 (Q1 2025), 0.01 (Q4 2024), and 0.06 (Q3 2021).